Quantcast

MiMedx Group (MDXG) Soars: Stock Adds 11.2% in Session


Shutterstock photo

MiMedx Group, Inc. MDXG was a big mover last session, as the company saw its shares rise more than 11% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend of the company, as the stock is now trading above the volatile price range of $6.97 to $8.24 in the past one-month time frame.

The company has seen no estimate revisions over the past few weeks and the Zacks Consensus Estimate for the current quarter remained unchanged. The recent price action is encouraging though, so make sure to keep a close watch on this firm in the near future.

MiMedx Group currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.  

MiMedx Group, Inc Price

MiMedx Group, Inc Price | MiMedx Group, Inc Quote

A better-ranked stock in the Medical - Biomedical and Genetics industry is Aeterna Zentaris Inc. AEZS , which currently carries a Zacks Rank #1 (Strong Buy). You can see  the complete list of today's Zacks #1 Rank stocks here .

Is MDXG going up? Or down? Predict to see what others think: Up or Down

Wall Street's Next Amazon

Zacks EVP Kevin Matras believes this familiar stock has only just begun its climb to become one of the greatest investments of all time. It's a once-in-a-generation opportunity to invest in pure genius.

Click for details >>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

AEterna Zentaris Inc. (AEZS): Free Stock Analysis Report

MiMedx Group, Inc (MDXG): Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.



This article appears in: Investing , Investing Ideas , Stocks
Referenced Symbols: AEZS , MDXG


More from Zacks.com

Subscribe






Zacks.com
Contributor:

Zacks.com

Equity Research








Research Brokers before you trade

Want to trade FX?